CYTOKINETICS ANNOUNCES MHRA MARKETING AUTHORISATION FOR MYQORZO®▼ (AFICAMTEN) AND POSITIVE GUIDANCE FROM NICE FOR SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN ENGLAND AND WALES

Reuters · 2d ago

Please log in to view news